Literature DB >> 8624106

The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.

D H Small1, T Williamson, G Reed, H Clarris, K Beyreuther, C L Masters, V Nurcombe.   

Abstract

The hallmark of Alzheimer's disease (AD) is the deposition of amyloid plaques and neurofibrillary tangles in the brain. The relationship between amyloid deposition and the cognitive deficit is still unclear. The amyloid beta A4 protein is produced by proteolytic cleavage of the amyloid protein precursor (APP). Very little is known about the normal function of APP and the role the protein may play in pathogenesis. Several studies have shown that APP is important for the regulation of neurite outgrowth. Our studies support these findings and indicate that the neurite outgrowth-promoting effects of APP are stimulated by an interaction between APP and specific proteoglycans. Using site-directed mutagenesis, a heparan sulfate binding site which mediates this effect has been mapped to the N-terminus of APP (residues 96-110, HBD-1). A peptide homologous to HBD-1 blocks the trophic effects of APP in cell culture. To purify specific proteoglycans which stimulate the action of APP, an affinity column was constructed using a biotinylated peptide homologous to HBD-1 coupled to streptavidin-agarose. Two proteoglycans were isolated from a crude brain cell conditioned medium by affinity chromatography. The purified proteoglycans bound APP saturably with high affinity and stimulated the action of APP on neurite outgrowth from chick sympathetic neurons. Digestion of the proteoglycan fraction with heparitinase I or chondroitinase ABC demonstrated the presence of two major proteins, a heparan sulfate proteoglycan with a core protein of 63-67 kD molecular mass and a chondroitin sulfate proteoglycan with a core protein of 100-110 kD molecular mass. The results demonstrate that APP binds to at least two proteoglycans and that this interaction may regulate the trophic effects of the protein. The interaction of specific APP-binding proteoglycans with amyloid plaques may disturb the normal function of APP and contribute to the neuritic degeneration that is commonly seen around the amyloid plaque cores.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624106     DOI: 10.1111/j.1749-6632.1996.tb34439.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

Authors:  J E Donahue; T M Berzin; M S Rafii; D J Glass; G D Yancopoulos; J R Fallon; E G Stopa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Role of glycosaminoglycans in determining the helicity of paired helical filaments.

Authors:  M Arrasate; M Pérez; J M Valpuesta; J Avila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Targeting heparin and heparan sulfate protein interactions.

Authors:  Ryan J Weiss; Jeffrey D Esko; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2017-06-27       Impact factor: 3.876

4.  Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment.

Authors:  M Pérez; F Wandosell; C Colaço; J Avila
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

Review 5.  The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton.

Authors:  Sara H Mokhtar; Maha M Bakhuraysah; David S Cram; Steven Petratos
Journal:  Int J Alzheimers Dis       Date:  2013-12-12

6.  Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42).

Authors:  Tamás Letoha; Anett Hudák; Erzsébet Kusz; Aladár Pettkó-Szandtner; Ildikó Domonkos; Katalin Jósvay; Martin Hofmann-Apitius; László Szilák
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

7.  Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.

Authors:  Ismael Santa-Maria; Félix Hernández; Joaquín Del Rio; Francisco J Moreno; Jesús Avila
Journal:  Mol Neurodegener       Date:  2007-09-06       Impact factor: 14.195

8.  Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell Signaling.

Authors:  Rosebud O Roberts; Yoo Na Kang; Chunling Hu; Catherine D Moser; Shaoqing Wang; Michael J Moore; Rondell P Graham; Jin-Ping Lai; Ronald C Petersen; Lewis R Roberts
Journal:  J Alzheimers Dis Rep       Date:  2017-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.